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Abstract The effects of caffeic acid (CA) and chlorogenic acid
(CHA), an ester of caffeic acid with quinic acid, were studied on
isolated human Cu
2+
-induced low density lipoprotein (LDL)
oxidation in initiation and propagation phases by measuring the
formation of thiobarbituric acid reactive substances (TBARS),
detecting conjugated diene and investigating the electrophoretic
mobility change of LDL. Both non-flavonoids exhibited proox-
idant and antioxidant activities depending on the LDL oxidation
phases. CA and CHA (0.1 WM or more) enhanced LDL
oxidation in the propagation phase. In agreement with previous
findings, 0.5 WM CA and CHA inhibited LDL oxidation in the
initiation phase. When 0.5 WM CA was added at 0 min, the
duration of inhibition was about 60 min. Yet, after s 9 min
incubation with Cu
2+
, 0.5 WM CA accelerated LDL oxidation.
The acceleration ratios were modified depending on the oxidation
process and the concentration of added CA in the propagation
phase. The maximum acceleration ratio was about 5 on addition
of 2^5 WMCA, attained after 40 min incubation with Cu
2+
. Even
in the propagation phase, an elevated concentration of CA
inhibited oxidation; after 20 min incubation with Cu
2+
, CA at
s 3 WM functioned as an inhibitor. Further studies must be
performed in order to clarify the counteracting deleterious
prooxidant conditions of these widespread natural dietary
compounds.
z 1997 Federation of European Biochemical Societies.
Key words: Ca¡eic acid; Chlorogenic acid; Ascorbic acid;
Prooxidant; Antioxidant; Low-density lipoprotein
1. Introduction
Ca¡eic acid (CA) and chlorogenic acid (CHA) are non-£a-
vonoid phenolic compounds from plants and are found nat-
urally in various foodstu¡s and beverages such as co¡ee beans
and their soluble constituents, potatoes, fruits like apples and
their juices, tobacco leaves, olive oil and wines [1^4]. There is
growing interest in the multiple biological and pharmacolog-
ical properties of non-£avonoid phenolic compounds such as
CA and CHA [5]. They have been reported to have anti-in-
£ammatory, cocarcinogenic, antimutagenic and anticarcino-
genic activities [4,6^9]. Particular attention has been paid to
the antioxidative actions of these widespread dietary phenolic
compounds [4^12]. CA and CHA have also been reported to
stimulate hydroxyl radical formation and reduce ferrylmyo-
globin [13^15], which suggests their potential prooxidant ac-
tion.
In the pathogenesis of atherosclerosis, recent reports sug-
gest that oxidative modi¢cation of low-density lipoprotein
(LDL) may play an important role in the initiation and pro-
gression of atherosclerosis and that lipid peroxidation has a
key role in its development [16]. Oxidation of LDL leads to its
uptake by a scavenger receptor on the surface of macrophages
that subsequently might result in foam cell formation [16].
Endothelial cells and macrophages are known to accelerate
LDL oxidation [17^19]. LDL oxidation is also catalyzed by
heavy metals such as Cu
2
and Fe
3
[20,21]. ln contrast, anti-
oxidants such as probucol and ascorbic acid were shown to
prevent LDL oxidation [22,23] and probucol was found to
protect against spontaneous atherosclerotic changes [24].
The above-described observations provide evidence that oxi-
dation of LDL is involved in the initiation and progression of
atherosclerosis and that protection against LDL oxidation is
critical to prevent the development of atherosclerosis.
Autoxidation of LDL is a free radical chain reaction which
is known to consist of the phases of initiation, propagation
and termination reactions [25]. Recently, we established that
catechins such as (3)-epicatechin and (3)-epigallocatechin
(£avan-3-ol derivatives, £avonoids abundant in green tea
leaves) possess the antioxidative and prooxidative character-
istics of Cu
2
-induced LDL oxidation during the process of
oxidation [26]. In the initiation phase, LDL oxidation was
inhibited by catechin addition. ln contrast, during the prop-
agation phase of LDL oxidation, catechins worked as accel-
erators of oxidation. Therefore, in the present study, we in-
vestigated the e¡ects of CA and CHA on the initiation and
propagation phases. We found that during the initial phase of
LDL oxidation the duration of inhibition was gradually re-
duced with respect to the time of addition of CA or CHA and
¢nally, that CA and CHA exerted accelerative e¡ects on the
propagation phase. Nevertheless, the concentration of non-
£avonoids modi¢ed the prooxidative and antioxidative activ-
ities.
2. Materials and methods
2.1. Chemicals
CA (3,4-dihydroxycinnamic acid) and CHA (3-(3,4-dihydroxycinna-
moyl)quinic acid) were obtained from Sigma (St. Louis, MO). 1-Hy-
droxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene (NOC5), which
generates nitric oxide (NO), was from Dojin Chemicals (Kumamoto,
Japan). Ascorbic acid (3-oxo-L-gulofuranolactone) and other chemi-
cals were from Wako Pure Chemicals (Tokyo, Japan).
2.2. Isolation of human LDL
LDL was prepared from human plasma of healthy donors by ultra-
centrifugation as described [27] with a density of cut-o¡ 1.005^1.065
and then dialyzed with 20 mM sodium phosphate bu¡er, pH 7.2,
containing 0.15 M sodium chloride and 2 WM EDTA to prevent the
oxidation of LDL [28]. LDL was stocked in N
2
gas saturated vials at
4³C and used within 1 week. Healthy donors gave their informed
consent according to the Declaration of Helsinki. Protein concentra-
tion of LDL was measured using the Bio-Rad protein assay kit (Bio-
Rad Laboratories, Richmond, CA) with bovine serum albumin as
standard.
FEBS 18330 24-10-97
0014-5793/97/$17.00 ß 1997 Federation of European Biochemical Societies. All rights reserved.
PII S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 1 8 5 - 3
*Corresponding author. Fax: (81) 5617-5-1605.
FEBS 18330FEBS Letters 405 (1997) 186^190
2.3. LDL oxidation
LDL solution (0.2 mg protein/ml) was prepared by dilution of iso-
lated LDL solution with 0.1 M sodium phosphate bu¡er, pH 7.2,
containing 0.15 M sodium chloride and 0.2 WM EDTA (PBS-
EDTA). LDL solutions were incubated with 5 WM CuSO
4
at 37³C
in the presence or absence of CA or CHA in the initiation and prop-
agation phases of oxidation.
2.4. Measurement of LDL peroxidation
Lipid peroxidation was estimated as thiobarbituric acid-reactive
substances (TBARS) £uorometrically and/or measured by absorbance
at 234 nm to detect conjugated dienes [28]. In TBARS analysis, ma-
londialdehyde (MDA) formed from 1,1,3,3-tetraethoxypropane was
used as a reference standard and the results were expressed as nmol
equivalent of MDA. These experiments were repeated two or three
times, the results obtained being almost the same. Sample-to-sample
variations from di¡erent volunteers were recognized. Typical results
are shown in the ¢gures.
2.5. Agarose gel electrophoretic mobility change of LDL
Agarose gel electrophoresis was performed to evaluate the electro-
phoretic mobility of LDL. Aliquots (50 Wg/250 Wl of LDL protein)
were concentrated 5-fold using an Ultrafree Concentrator (C3LCC,
Millipore). This was performed by centrifugation at 5000Ug for 120
min at 4³C. 8 Wl of the concentrated samples were applied to 1%
agarose gel electrophoresis. The gel was stained with 0.25% Coomas-
sie Brilliant blue in 7% acetic acid.
3. Results
The e¡ects of 0.5 WM CA and CHA were examined on
Cu
2
-induced LDL oxidation during the initiation (0 min)
and propagation (20 min incubation with Cu
2
) phases. As
shown in Fig. 1A,B, CA and CHA inhibited LDL oxidation
in the initiation phase consistent with previous reports
[5,11,12]. In contrast, it is evident that in the propagation
phase, both CA and CHA accelerated LDL oxidation. How-
ever, 5 WM CA inhibited LDL oxidation even in the propa-
gation phase (Fig. 1A) and CHA also exhibited the same
e¡ect (data not shown). 0.5 WM ascorbic acid (non-phenolic
acid) also displayed the same antioxidative and prooxidative
e¡ects on LDL oxidation as elicited by CA and CHA (Fig.
1B). 5 WM ascorbic acid inhibited oxidation during the prop-
agation phase (20 min after Cu
2
addition) (data not shown).
Nevertheless, NO released from NOC5 inhibited even CA-
accelerated LDL oxidation (Fig. 1A), which was also ob-
served in the case of catechins (£avan-3-ol derivatives, £avo-
noid) [26]. NO functioned as an antioxidant during all phases
of LDL oxidation, even when present at low concentration
(data not shown). 0.5 WM ascorbic acid did not inhibit CA-
and CHA-accelerated LDL oxidation, but rather accelerated
the e¡ects of CA and CHA (data not shown). As shown in
Fig. 2, the e¡ect of CA concentration was examined on
changes in electrophoretic mobility of LDL on agarose gel
electrophoresis for LDL oxidation. The mobility changes
were accelerated by CA (0.5 and 1.0 WM) in the propagation
phase (Fig. 2). However, 5.0 WM CA inhibited the mobility
change. These results indicated that higher concentrations of
CA inhibited the oxidation and mobility even in the propa-
gation phase, in accordance with the TBARS formation
shown in Figs. 1A and 4. CHA also demonstrated the same
tendency, but CA was more e¡ective (data not shown). The
e¡ects of CA on LDL oxidation were examined with respect
to time after Cu
2
addition by following the formation of
TBARS and detection of conjugated dienes (Fig. 3A,B). 0.5
WM CA additions at 0^6 min incubation with Cu
2
inhibited
the formation of both TBARS and conjugated dienes. The
duration of inhibition gradually decreased. After 12 min in-
cubation of LDL with Cu
2
, CA accelerated the oxidation,
the rate of acceleration gradually increasing up to 20 min
incubation with Cu
2
(Fig. 3). As shown in Fig. 4, the max-
imum rate of acceleration and ratio were obtained at 40 min
FEBS 18330 24-10-97
Fig. 1. Accelerative and inhibitory e¡ects of CA and CHA on Cu
2
-induced TBARS formation in LDL. Left: E¡ects of 0.5 and 5.0 WM CA
in the propagation phase and inhibitory e¡ect of NO released from NOC5 on CA accelerated Cu
2
-induced LDL oxidation. LDL (0.2 mg pro-
tein/ml) was dissolved in 10 ml of PBS-EDTA and the reaction was initiated by adding 5 WM CuSO
4
at 37³C. The reaction mixture (R.M.) (10
ml) was used to measure TBARS formation as control (a). After 20 min incubation, R.M. (4.0 ml) was separated and 0.5 WM CA was added
(R). 10 min after the addition of 0.5 WM CA, 2.0 ml R.M. with 0.5 WM CA was removed and 5 WM NOC5 was added (O). After 20 min in-
cubation of R.M. (2.0 ml), 5.0 WM CA was added (U). In 2.0 ml of R.M., 0.5 WM CA was added at 0 min as the initiation phase (b). TBARS
formation was measured at 20-min intervals using an aliquot (100 Wl) as described in Section 2. Right: E¡ects of 0.5 WM CHA and ascorbic
acid in initiation and propagation phases. LDL (0.2 mg protein/ml) was dissolved in 10 ml of PBS-EDTA and the reaction was initiated by
adding 5 WM CuSO
4
at 37³C, designated R.M. TBARS formation was measured at every 20 min using an aliquot (100 Wl) as described in Sec-
tion 2. R.M. (6.0 ml) was used to measure TBARS formation as control (a). After 20 min incubation, R.M. (2.0 ml portions) was removed
and 0.5 WM CHA (R) or 0.5 WM ascorbic acid was added (P). To each 2.0 ml aliquot of R.M., 0.5 WM CHA (b) or 0.5 WM ascorbic acid
(U) was added at 0 min as the initiation phase.
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incubation. The acceleration and inhibition ratios in the prop-
agation phase of LDL oxidation as measured by TBARS
formation varied as a function of CA concentration and
time of oxidation (Fig. 4). After 20 min incubation of LDL
with 5 WM Cu
2
(b), 0.1 WM CA accelerated the oxidation
process, the ratio being about 1.7 and the maximum acceler-
ation ratio amounted to approx. 2.9 at 0.5^2.0 WM CA. How-
ever, CA at s 3.0 WM tended to inhibit oxidation, even in the
propagation phase. 5.0 and 10 WM CA inhibited LDL oxida-
tion and the acceleration ratio was near to 32.0, indicating
that CA reduced the extent of TBARS formation as shown in
Fig. 1A. The decrease in TBARS formation due to CA might
be explained as follows. Phenolic compounds such as CA
withdraw peroxyl and/or alkoxyl radicals from the chain re-
action [9] and the hydroperoxide derivatives formed might be
reversed during the initial phase. The maximum acceleration
ratio with CA was about 5, which was attained at 40 min
incubation of LDL with Cu
2
during the propagation phase
and the CA concentration was in the range 2.0^5.0 WM. In-
cubation of LDL for 60^100 min with Cu
2
in the propaga-
tion phase gradually lowered the acceleration ratio. Neverthe-
less, CA even at 10 WM still resulted in acceleration, the ratio
being about 1.5^3.5 (O, R and U).
4. Discussion
In accordance with previous papers [5,9^12], the non-£avo-
noid, naturally abundant dietary phenolic compounds, CA
and CHA, were con¢rmed to inhibit Cu
2
-induced LDL ox-
idation in the initiation phase. However, during the oxidation
step from initiation to propagation, we found the duration of
inhibition by CA to decrease gradually, the inhibitory e¡ect
being completely abolished (Fig. 3). Furthermore, we ob-
served that CA and CHA accelerated the rates of LDL oxi-
dation in the propagation phase. This ¢nding means that CA
and CHA exert prooxidant activities against free radical chain
reactions such as lipid peroxidation. Laranjinha et al. [5], even
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Fig. 2. Cu
2
-induced mobility changes of LDL using 1% agarose
gel electrophoresis in the presence of various concentration of CA.
1 ml of each LDL (0.2 mg protein/ml in PBS-EDTA) solution was
incubated with 5 WM CuSO
4
at 37³C. After 20 min incubation, the
indicated concentration of CA was added to each reaction mixture.
After 20 min incubation with or without the indicated concentration
of CA, 250 Wl of the reaction mixture was removed to perform
agarose gel electrophoresis as described in Section 2. 250 Wl of the 0
and 20 min incubation samples without CA addition were also used
as control. 0.1 mM EDTA was added to stop the reaction.
Fig. 3. Inhibitory and accelerative modi¢cations of CA e¡ects on Cu
2
-induced LDL oxidation in the initiation and propagation phases. (A)
E¡ects on TBARS formation. LDL (0.2 mg protein/ml) was dissolved in 20 ml PBS-EDTA and the reaction was initiated with the addition of
5 WM CuSO
4
at 37³C. A 2.0 ml aliquot was removed and 0.5 WM CA was added every 3 min except for the 20 min incubation sample. A 100
Wl aliquot was taken from each reaction mixture at 20-min intervals after Cu
2
addition in order to measure TBARS formation as described in
Section 2. (a) No CA, (b) 0.5 WM CA at 0 min, (O) 0.5 WM CA at 3 min, (R) 0.5 WM CA at 6 min, (P) 0.5 WM CA at 9 min, (S) 0.5 WM
CA at 12 min, (h) O.5 WM CA at 15 min, (U) 0.5 WM CA at 20 min. (B) E¡ects on conjugated diene formation. LDL (0.2 mg protein/ml)
was dissolved in 32 ml PBS-EDTA and the reaction was initiated as described in A. A 4.0 ml aliquot was removed and 0.5 WM CA was added
as described in A. Formation of conjugated diene was measured at 20-min intervals as described in Section 2. All symbols correspond to those
in A and under the same experimental conditions.
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though they did not provide data, reported that non-£avo-
noids such as CA or CHA were probably added during the
propagation step of LDL peroxidation. However, they did not
observe an accelerative e¡ect, but rather an inhibitive e¡ect
because of the higher concentration of non-£avonoid. The
prooxidant characteristics of CA and CHA were suggested
in previous papers [13^15]. The e¡ects of CA and CHA on
the Fenton reaction were examined by using the ESR spin
trapping technique [13]. CA and CHA (10 WM to 10 mM
level) stimulated the formation of hydroxyl radicals in a re-
action mixture containing H
2
O
2
, FeCl
3
and EDTA. However,
in the presence of 3-hydroxyanthranic acid with H
2
O
2
and
FeCl
3
, CA and CHA resulted in a decrease of hydroxyl rad-
ical formation [14]. CA and CHA reduced ferrylmyoglobin
and, during the electron-transfer reactions, CA and CHA
were oxidized to quinoid forms [15]. The above reports indi-
cate that CA and CHA exert apparently con£icting e¡ects
depending on the oxidation conditions and that they are po-
tential prooxidants.
In our experiments, 0.75 WM CA and 0.2 WM EDTA with-
out Cu
2
, or 0.75 WM CA, 0.2 WM EDTA and 1 mM H
2
O
2
without Cu
2
did not stimulate LDL oxidation (data not
shown). The results indicate that the Fenton reaction might
not be involved and that Cu
2
is essential in our system. In
the propagation phase at 20 and 40 min incubation with
Cu
2
, the accelerative e¡ects of 0.75 WM CA clearly remained
unchanged on the addition of 1 mM H
2
O
2
; the addition of
catalase (1^10 units/ml) to the CA-accelerated LDL oxidation
system was also without e¡ect (data not shown). Therefore, in
our experimental systems, iron, EDTA and H
2
O
2
might not
be related. Changes in Cu
2
concentration (0.5^5.0 WM) with
1.0 WM CA did not a¡ect the duration of inhibition and initial
rate of TBARS formation during the initiation phase (0 min
CA addition) (data not shown). The results suggest that che-
lation of copper ion with CA might not be critical for the
e¡ects of CA as suggested by Nardini et al. [11].
Ascorbic acid is known to switch from anti- to pro-oxidant
activity, depending on its concentration and on the presence
of free transition metal ions [29]. Frei reported that ascorbic
acid completely protected lipid in plasma and LDL against
detectable peroxidative damage and was reactive enough to
intercept oxidants in the aqueous phase before they could
attack and cause detectable oxidative damage to lipids [30].
However, in our experiment (Fig. 1B), ascorbic acid displayed
antioxidative and prooxidative activities depending on the ox-
idation state of LDL, similar to the e¡ects demonstrated by
CA and CHA. The 0.5 WM CA-accelerated propagation rate
was further stimulated by 0.5 WM ascorbic acid (data not
shown), indicating that ascorbic acid did not work as an anti-
oxidant. Phenolic compounds are known to quench OH
c
quite
e¤ciently and are also supposed to withdraw peroxyl and
alkoxyl radicals from the chain reaction that consequently
breaks down the autoxidation process [9]. Moreover, even
K-tocopherol, a well-known antioxidant, has been reported
to stimulate Cu
2
-initiated lipid peroxidation when phospho-
lipids and traces of their hydroperoxide derivatives are in-
cluded [31].
In our experiments, non-£avonoids (CA and CHA) as well
as catechins (£avan-3-ol derivatives, £avonoids) [26] and as-
corbic acid (non-phenolic compound) have been shown to
inhibit Cu
2
-induced LDL oxidation in the initiation phase.
However, in the propagation phase, the above-described com-
pounds worked as prooxidants and exhibited same trends.
Depending upon the redox status, non-£avonoids might
form reactive oxidation products such as semiquinones and
quinones and function to stimulate oxidative reactions. All
such common natural foodstu¡s and beverages should be
carefully studied in ordrer to determine the conditions of de-
veloping deleterious e¡ects, since prooxidant states may play
important roles in atherogenesis, aging and cancer.
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